About Lethal congenital contracture syndrome type 2

What is Lethal congenital contracture syndrome type 2?

Lethal congenital contracture syndrome type 2 (LCCS2) is a rare genetic disorder characterized by severe joint contractures, muscle weakness, and respiratory failure. It is caused by mutations in the gene encoding the protein lamin A/C, which is involved in the formation of the nuclear envelope. Affected individuals typically die in infancy due to respiratory failure.

What are the symptoms of Lethal congenital contracture syndrome type 2?

The symptoms of Lethal congenital contracture syndrome type 2 (LCCS2) include:

- Severe joint contractures of the hands, feet, and elbows
- Severe muscle weakness
- Poor muscle tone
- Respiratory distress
- Feeding difficulties
- Seizures
- Intellectual disability
- Abnormal facial features
- Abnormal skull shape
- Abnormalities of the eyes, ears, and nose
- Abnormalities of the heart, lungs, and kidneys
- Abnormalities of the gastrointestinal tract
- Abnormalities of the genitalia and urinary tract

What are the causes of Lethal congenital contracture syndrome type 2?

Lethal congenital contracture syndrome type 2 (LCCS2) is caused by mutations in the gene encoding the protein laminin-alpha-2 (LAMA2). Mutations in this gene lead to a deficiency of laminin-alpha-2, which is a major component of the extracellular matrix that provides structural support to cells. This deficiency leads to the development of contractures, which are permanent shortening of muscles and tendons, resulting in joint deformities and impaired movement.

What are the treatments for Lethal congenital contracture syndrome type 2?

Unfortunately, there is no known cure for Lethal congenital contracture syndrome type 2. Treatment focuses on managing the symptoms and providing supportive care. This may include physical therapy to help maintain range of motion, occupational therapy to help with activities of daily living, and speech therapy to help with communication. Medications may also be prescribed to help manage pain and other symptoms.

What are the risk factors for Lethal congenital contracture syndrome type 2?

1. Autosomal recessive inheritance
2. Mutations in the RAPSN gene
3. Maternal diabetes
4. Advanced maternal age
5. Exposure to certain medications or toxins during pregnancy
6. Low birth weight
7. Premature birth
8. Exposure to certain infections during pregnancy

Is there a cure/medications for Lethal congenital contracture syndrome type 2?

At this time, there is no known cure for Lethal Congenital Contracture Syndrome Type 2 (LCCS2). However, there are medications that can help manage the symptoms of the condition. These medications include muscle relaxants, anticonvulsants, and pain medications. Physical therapy and occupational therapy can also help improve the quality of life for those with LCCS2.